|
Siemens filed the initial mdr 9610806-2025-00054 on 10-dec-2025.Additional information received 19-dec-2025: siemens reviewed the information provided and data obtained.The differences in results likely stem from multiple factors, including variations in methodology, calibration, and reference ranges, which can affect both values and interpretation.For instance, a recent thrombotic event could explain decreased protein c activity, but the original data suggests this alone may not account for the reduction, possibly indicating a deficiency that requires further investigation.Quality control data show all levels within acceptable limits, confirming the instrument is functioning properly.Therefore, the observed differences are most likely due to assay principles (siemens vs.Alternate method) and reagent variability.Based on the available information, a single root cause cannot be definitively assigned.The most plausible explanation remains methodological and reagent differences between the siemens and alternate systems, rather than an analytical error.Assessment of instrument performance included a review of qc (quality control) results have been found within range on the complained day no hardware or software errors could be found in the logs calibration curve was checked, which looks inconspicuous sample results were unflagged.Reagent issues were ruled out based on review of qc which showed recovery within acceptable ranges.Customer is operational, system works as specified.In section h6, the investigation findings and investigation conclusions codes were updated.The reported behavior was resolved by standard service actions/routine troubleshooting the instrument is performing according to specifications.No further evaluation of this device is required.
|